Kyverna Therapeutics, Inc.

NasdaqGS:KYTX Stock Report

Market Cap: US$220.6m

Kyverna Therapeutics, Inc. Company Information

Kyverna Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Kyverna Therapeutics, Inc.
  • Ticker: KYTX
  • Exchange: NasdaqGS
  • Founded: 2018
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$220.607m
  • Shares Outstanding: 43.17m
  • Website: https://kyvernatx.com

Number of Employees


Location

  • Kyverna Therapeutics, Inc.
  • 5980 Horton Street
  • Suite 550
  • Emeryville
  • California
  • 94608
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
KYTXNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDFeb 2024

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/26 23:00
End of Day Share Price 2024/11/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.